8-70733906-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001011720.2(XKR9):āc.604A>Cā(p.Lys202Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,612,752 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001011720.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
XKR9 | NM_001011720.2 | c.604A>C | p.Lys202Gln | missense_variant | 5/5 | ENST00000408926.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
XKR9 | ENST00000408926.8 | c.604A>C | p.Lys202Gln | missense_variant | 5/5 | 1 | NM_001011720.2 | P1 | |
XKR9 | ENST00000520030.5 | c.604A>C | p.Lys202Gln | missense_variant | 6/6 | 1 | P1 | ||
XKR9 | ENST00000520092.5 | c.*344A>C | 3_prime_UTR_variant, NMD_transcript_variant | 6/6 | 2 | ||||
XKR9 | ENST00000520273.1 | n.352+26753A>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000800 AC: 2AN: 250042Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 135016
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1460550Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 726388
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 20, 2023 | The c.604A>C (p.K202Q) alteration is located in exon 5 (coding exon 3) of the XKR9 gene. This alteration results from a A to C substitution at nucleotide position 604, causing the lysine (K) at amino acid position 202 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at